换一批Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--the MIMOSA study.
第一作者：
Paul,Sabbatini
第一单位：
Kliniken Essen-Mitte, Germany. sabbatip@mskcc.org
作者：
医学主题词
腺癌, 黏液(Adenocarcinoma, Mucinous);抗体, 单克隆(Antibodies, Monoclonal);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);囊腺癌, 浆液(Cystadenocarcinoma, Serous);双盲法(Double-Blind Method);子宫内膜肿瘤(Endometrial Neoplasms);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);肿瘤, 腺和上皮(Neoplasms, Glandular and Epithelial);卵巢肿瘤(Ovarian Neoplasms);预后(Prognosis);存活率(Survival Rate)
DOI
10.1200/JCO.2012.46.4057
PMID
23478059
发布时间
2021-10-21
- 浏览47
Journal of clinical oncology
1554-61页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
